SGP SPYGLASS PHARMA SHS
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 9 analyst firms say about SPYGLASS PHARMA SHS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
7 rated views · 9 analyst/firm records · 9 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Fewer than 5 analysts in the last 6 months (4)
- Russell 2000 · Safest consensus · 6MNot scored · Fewer than 5 analysts in the last 6 months (4)
Recent analyst activity · last 90 days
Our tracked history has 5 reports on SGP from 4 analyst firms in the last 90 days (9 firms in the past year).
Comparing each firm's latest target with its previous one: 1 left it unchanged and 1 has its first observed target in the past year.
No firm's latest available rating differs from its previous one.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Citigroup | Yigal Nochomovitz | Buy | 3 Mar 2026 | 42.00 USD |
| H.C. Wainwright | Yi Chen | Buy | 21 Oct 2026 | 37.00 USD |
| Jefferies | Dennis Ding | Buy | 3 Mar 2026 | 62.00 USD |
| Leerink Partners | Marc Goodman | ConflictConflicting reports · excluded | 3 Mar 2026 | 42.00 USD |
| Raymond James | Chris Raymond | Buy | 14 Aug 2026 | 39.00 USD |
| Stifel | Tom Stephan | Buy | 3 Mar 2026 | 42.00 USD |
| UBS | Unnamed analyst | Buy | 5 Oct 2026 | — |
| Weiss Ratings | Unnamed analyst | — | 25 Sep 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 4 Mar 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 03:26 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.